Quantbot Technologies’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Quantbot Technologies’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10	Closed	-$1K	–	2231
2021 Q4	$1K	Buy	+10	New	+$1.27K	﹤0.01%	1435
2021 Q1	–	Sell	-1,778	Closed	-$152K	–	1923
2020 Q4	$152K	Buy	+1,778	New	+$151K	0.02%	664
2019 Q4	–	Sell	-450	Closed	-$18K	–	1761
2019 Q3	$18K	Sell	450 -150	-25%	-$6.34K	﹤0.01%	1122
2019 Q2	$26K	Buy	+600	New	+$33.8K	﹤0.01%	1005
2018 Q4	–	Sell	-2,066	Closed	-$77K	–	1681
2018 Q3	$77K	Sell	2,066 -48	-2%	-$1.77K	0.01%	945
2018 Q2	$83K	Buy	+2,114	New	+$67.1K	0.01%	910

Other funds holding BHVN

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Quantbot Technologies's BHVN Position: Q1 2022 in Review

Quantbot Technologies sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q1 2022, closing a stake of 10 shares — an estimated $1K sold.

Quantbot Technologies first reported a position in BHVN in Q2 2018 and held it in 6 quarters. The position peaked at $152K in Q4 2020. 307 funds tracked by Wall St. Rank hold BHVN as of Q1 2022.

Quantbot Technologies reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q1 2022 after selling out during the quarter.
Quantbot Technologies sold 10 Biohaven Pharmaceutical Holding Company Ltd. shares in Q1 2022, an estimated $1K.
Quantbot Technologies first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2018 and held it in 6 quarters.
Quantbot Technologies's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $152K in Q4 2020.
307 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q1 2022.

Based on Quantbot Technologies's 13F filing for Q1 2022, filed 16 May 2022.